Clinitech Laboratory Statistics
Total Valuation
BOM:544220 has a market cap or net worth of INR 74.68 million. The enterprise value is 87.31 million.
Important Dates
The last earnings date was Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:544220 has 2.28 million shares outstanding. The number of shares has increased by 3.30% in one year.
| Current Share Class | 2.28M |
| Shares Outstanding | 2.28M |
| Shares Change (YoY) | +3.30% |
| Shares Change (QoQ) | -33.48% |
| Owned by Insiders (%) | 97.10% |
| Owned by Institutions (%) | n/a |
| Float | 66,246 |
Valuation Ratios
The trailing PE ratio is 16.91.
| PE Ratio | 16.91 |
| Forward PE | n/a |
| PS Ratio | 0.54 |
| PB Ratio | 0.78 |
| P/TBV Ratio | 0.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | 18.16 |
| EV / Sales | 0.63 |
| EV / EBITDA | 5.85 |
| EV / EBIT | 9.38 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.50, with a Debt / Equity ratio of 0.33.
| Current Ratio | 5.50 |
| Quick Ratio | 3.12 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 2.11 |
| Debt / FCF | n/a |
| Interest Coverage | 8.50 |
Financial Efficiency
Return on equity (ROE) is 5.92% and return on invested capital (ROIC) is 6.81%.
| Return on Equity (ROE) | 5.92% |
| Return on Assets (ROA) | 3.71% |
| Return on Invested Capital (ROIC) | 6.81% |
| Return on Capital Employed (ROCE) | 7.14% |
| Weighted Average Cost of Capital (WACC) | 5.04% |
| Revenue Per Employee | 854,019 |
| Profits Per Employee | 29,685 |
| Employee Count | 162 |
| Asset Turnover | 1.07 |
| Inventory Turnover | 5.69 |
Taxes
In the past 12 months, BOM:544220 has paid 3.03 million in taxes.
| Income Tax | 3.03M |
| Effective Tax Rate | 35.21% |
Stock Price Statistics
The stock price has decreased by -18.20% in the last 52 weeks. The beta is 0.36, so BOM:544220's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | -18.20% |
| 50-Day Moving Average | 37.93 |
| 200-Day Moving Average | 45.08 |
| Relative Strength Index (RSI) | 41.11 |
| Average Volume (20 Days) | 2,880 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:544220 had revenue of INR 138.35 million and earned 4.81 million in profits. Earnings per share was 1.93.
| Revenue | 138.35M |
| Gross Profit | 85.34M |
| Operating Income | 9.31M |
| Pretax Income | 8.60M |
| Net Income | 4.81M |
| EBITDA | 14.92M |
| EBIT | 9.31M |
| Earnings Per Share (EPS) | 1.93 |
Full Income Statement Balance Sheet
The company has 19.75 million in cash and 31.53 million in debt, with a net cash position of -11.79 million or -5.17 per share.
| Cash & Cash Equivalents | 19.75M |
| Total Debt | 31.53M |
| Net Cash | -11.79M |
| Net Cash Per Share | -5.17 |
| Equity (Book Value) | 96.96M |
| Book Value Per Share | 48.42 |
| Working Capital | 79.58M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -11.57 million and capital expenditures -22.84 million, giving a free cash flow of -34.42 million.
| Operating Cash Flow | -11.57M |
| Capital Expenditures | -22.84M |
| Depreciation & Amortization | 5.61M |
| Net Borrowing | 29.81M |
| Free Cash Flow | -34.42M |
| FCF Per Share | -15.08 |
Full Cash Flow Statement Margins
Gross margin is 61.68%, with operating and profit margins of 6.73% and 3.48%.
| Gross Margin | 61.68% |
| Operating Margin | 6.73% |
| Pretax Margin | 6.21% |
| Profit Margin | 3.48% |
| EBITDA Margin | 10.78% |
| EBIT Margin | 6.73% |
| FCF Margin | n/a |
Dividends & Yields
BOM:544220 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.30% |
| Shareholder Yield | -3.30% |
| Earnings Yield | 5.91% |
| FCF Yield | -46.09% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |